Harbin Medisan Pharmaceutical Salute del bilancio
Salute finanziaria criteri di controllo 3/6
Harbin Medisan Pharmaceutical has a total shareholder equity of CN¥2.1B and total debt of CN¥906.2M, which brings its debt-to-equity ratio to 42.2%. Its total assets and total liabilities are CN¥3.6B and CN¥1.4B respectively.
Informazioni chiave
42.2%
Rapporto debito/patrimonio netto
CN¥906.17m
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | CN¥840.63m |
| Patrimonio netto | CN¥2.15b |
| Totale passività | CN¥1.41b |
| Totale attività | CN¥3.56b |
Aggiornamenti recenti sulla salute finanziaria
Recent updates
Harbin Medisan Pharmaceutical (SZSE:002900) Posted Weak Earnings But There Is More To Worry About
Sep 05
Harbin Medisan Pharmaceutical (SZSE:002900) Will Pay A Larger Dividend Than Last Year At CN¥0.20
Jun 01Is Harbin Medisan Pharmaceutical (SZSE:002900) A Risky Investment?
May 23Harbin Medisan Pharmaceutical Co., Ltd.'s (SZSE:002900) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Mar 08Analisi della posizione finanziaria
Passività a breve termine: 002900's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥1.1B).
Passività a lungo termine: 002900's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥337.6M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 002900's net debt to equity ratio (3.1%) is considered satisfactory.
Riduzione del debito: 002900's debt to equity ratio has increased from 11% to 42.2% over the past 5 years.
Copertura del debito: 002900's operating cash flow is negative, therefore debt is not well covered.
Copertura degli interessi: Insufficient data to determine if 002900's interest payments on its debt are well covered by EBIT.